Oral nucleoside/nucleotide analogs without hepatitis B immune globulin after liver transplantation for hepatitis B. (Q45299212)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23629601 AND SRC:MED&resulttype=core&format=json

29 February 2020

title

Oral nucleoside/nucleotide analogs without hepatitis B immune globulin after liver transplantation for hepatitis B (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23629601 AND SRC:MED&resulttype=core&format=json

29 February 2020

main subject

liver transplantation

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23629601 AND SRC:MED&resulttype=core&format=json

29 February 2020

Kenneth Siu Ho Chok

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23629601 AND SRC:MED&resulttype=core&format=json

29 February 2020

Seto WK

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23629601 AND SRC:MED&resulttype=core&format=json

29 February 2020

Ching-Lung Lai

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23629601 AND SRC:MED&resulttype=core&format=json

29 February 2020

4

Man-Fung Yuen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23629601 AND SRC:MED&resulttype=core&format=json

29 February 2020

7

Albert Chi-Yan Chan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23629601 AND SRC:MED&resulttype=core&format=json

29 February 2020

2

See-Ching Chan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23629601 AND SRC:MED&resulttype=core&format=json

29 February 2020

10

Sheung-Tat Fan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23629601 AND SRC:MED&resulttype=core&format=json

29 February 2020

6

William Sharr

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23629601 AND SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Cindy Cheung

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23629601 AND SRC:MED&resulttype=core&format=json

29 February 2020

Tan-To Cheung

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23629601 AND SRC:MED&resulttype=core&format=json

29 February 2020

Chung-Mau Lo

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23629601 AND SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

English

0 references

publication date

30 April 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23629601 AND SRC:MED&resulttype=core&format=json

The American Journal of Gastroenterology

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23629601 AND SRC:MED&resulttype=core&format=json

29 February 2020

volume

108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23629601 AND SRC:MED&resulttype=core&format=json

29 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23629601 AND SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

942-948

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23629601 AND SRC:MED&resulttype=core&format=json

A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B.

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/AJG.2013.111

Lamivudine without HBIg for prevention of graft reinfection by hepatitis B: long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2013.111

Liver transplantation in Asian patients with chronic hepatitis B using lamivudine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2013.111

Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2013.111

A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2013.111

A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2013.111

Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2013.111

Liver transplantation for chronic hepatitis B with lamivudine-resistant YMDD mutant using add-on adefovir dipivoxil plus lamivudine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2013.111

Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2013.111

Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2013.111

Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2013.111